New patent for Avadel Cns drug LUMRYZ

   October 25, 2023    Comments Off on New patent for Avadel Cns drug LUMRYZ    Posted in: Patent Added

Annual Drug Patent Expirations for LUMRYZ Lumryz is a drug marketed by Avadel Cns and is included in one NDA. It is available from one supplier. There are thirteen patents…

The post New patent for Avadel Cns drug LUMRYZ appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog